Home

Pasithea Therapeutics Corp. - Common Stock (KTTA)

0.2923
-0.1228 (-29.58%)
NASDAQ · Last Trade: Nov 22nd, 5:01 AM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Top stock movements in today's session.chartmill.com
Stay up-to-date with the latest market trends one hour before the close of the markets on Friday. Explore the top gainers and losers during today's session in our detailed report.
Via Chartmill · November 21, 2025
Which stocks have an unusual volume on Friday?chartmill.com
Which stocks have an unusual volume on Friday?
Via Chartmill · November 21, 2025
Let's take a look at the stocks that are in motion in today's session.chartmill.com
Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via Chartmill · November 21, 2025
Friday's pre-market session: top gainers and loserschartmill.com
As the US market prepares to open on Friday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.
Via Chartmill · November 21, 2025
Get insights into the top gainers and losers of Thursday's after-hours session.chartmill.com
The regular session of the US market on Thursday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
Via Chartmill · November 20, 2025
12 Health Care Stocks Moving In Thursday's After-Market Sessionbenzinga.com
Via Benzinga · November 20, 2025
12 Health Care Stocks Moving In Friday's After-Market Sessionbenzinga.com
Via Benzinga · September 19, 2025
Pasithea Therapeutics Stock Draws Retail Buzz As Early Data Shows Potential In Treating Inflammatory Diseasesstocktwits.com
The company saw increased retail chatter after new preclinical data showed its drug, PAS-004, effectively blocks inflammation pathways linked to IBD and other immune diseases.
Via Stocktwits · May 20, 2025
Theriva Biologics Shares Plunge After Pricing $7.5M Offering: Retail Sentiment Still Strongstocktwits.com
The offering comes on the heels of encouraging data from the Virage Phase 2b trial, which demonstrated significant improvements in overall survival and duration of response for patients receiving Theriva's lead product candidate, VCN-01.
Via Stocktwits · May 7, 2025
12 Health Care Stocks Moving In Wednesday's Intraday Sessionbenzinga.com
Via Benzinga · May 7, 2025
Wednesday's session: top gainers and loserschartmill.com
Curious to know what's happening on the US markets in the middle of the day on Wednesday? Join us as we explore the top gainers and losers in today's session.
Via Chartmill · May 7, 2025
Which stocks are most active on Tuesday?chartmill.com
These stocks are making the most noise in today's session. Stay tuned for the latest updates!
Via Chartmill · May 6, 2025
Pasithea Therapeutics Stock Soars After Positive Data From Cancer Drug Trial: Retail’s Elatedstocktwits.com
The clinical-stage biotechnology company said several patients achieved stable disease and tumor shrinkage while on the treatment.
Via Stocktwits · May 6, 2025
Pasithea Therapeutics Drug Shows Tumor Reduction In Pancreatic Cancer, Strong Early Trial Resultsbenzinga.com
Pasithea shares rise as early Phase 1 data of PAS-004 shows strong pERK inhibition and tumor shrinkage in advanced cancer patients.
Via Benzinga · May 6, 2025
What's going on in today's pre-market sessionchartmill.com
Before the US market kicks off on Tuesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.
Via Chartmill · May 6, 2025
12 Health Care Stocks Moving In Tuesday's Pre-Market Sessionbenzinga.com
Via Benzinga · May 6, 2025
12 Health Care Stocks Moving In Monday's Pre-Market Sessionbenzinga.com
Via Benzinga · April 14, 2025
12 Health Care Stocks Moving In Friday's After-Market Sessionbenzinga.com
Via Benzinga · April 11, 2025
Pasithea Therapeutics Leads Healthcare Buzz Surge As Cancer Trial Clears Safety Hurdle, Moves To Next Dosing Cohortstocktwits.com
The decision was based on safety data from three patients in Cohort 5, with no dose-limiting toxicities reported.
Via Stocktwits · April 11, 2025
Top stock movements in today's session.chartmill.com
Stay up-to-date with the latest market trends one hour before the close of the markets on Thursday. Explore the top gainers and losers during today's session in our detailed report.
Via Chartmill · April 10, 2025
Most active stocks in Thursday's sessionchartmill.com
Let's have a look at what is happening on the US markets on Thursday. Below you can find the most active stocks in today's session.
Via Chartmill · April 10, 2025
Top movers analysis in the middle of the day on 2025-04-10: top gainers and losers in today's session.chartmill.com
Stay up-to-date with the latest market trends in the middle of the day on Thursday. Explore the top gainers and losers during today's session in our detailed report.
Via Chartmill · April 10, 2025
12 Health Care Stocks Moving In Thursday's Intraday Sessionbenzinga.com
Via Benzinga · April 10, 2025
These stocks are gapping in today's sessionchartmill.com
Let's delve into the US markets on Thursday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.
Via Chartmill · April 10, 2025
Crude Oil Falls Over 4%; Keros Therapeutics Shares Jumpmarkets/com
Via Benzinga · April 10, 2025